A weight off your chest
Imagine not having to worry about how you will manage your next episode of rapid heartbeat when it strikes. Milestone aims to provide that sense of security. We’re developing a nasal spray that fits in your pocket, so you can live confidently and fully.
OUR AREAS OF FOCUS
Delivering Cardiac Peace of Mind
Our focus is to fill the existing gap in therapy for the rapid termination of paroxysmal supraventricular tachycardia (PSVT) and other episodic cardiovascular conditions, including atrial fibrillation and angina, outside of the emergency department or hospital setting.
Paroxysmal
Supraventricular
Tachychardia
(PSVT)
Atrial Fibrillation
(AF)
Angina
OUR AREAS OF FOCUS
Delivering Cardiac Peace of Mind
Our focus is to fill the existing gap in therapy for the rapid termination of paroxysmal supraventricular tachycardia (PSVT) and other episodic cardiovascular conditions, including atrial fibrillation and angina, outside of the emergency department or hospital setting.
OUR PIPELINE
A Pocket-Sized Nasal Spray to the Rescue
We’ve designed and are developing the investigational drug, etripamil: a new, potent, and fast-acting calcium channel blocker in the form of a nasal spray to stop PSVT or other episodic cardiovascular conditions whenever and wherever they occur.
CLINICAL TRIALS
Our Heartfelt Thanks
We know that advancing scientific discovery is not possible without dedicated patient volunteers and researchers working together. Talking to your healthcare team can help you know whether a clinical trial is right for you and determine whether you are eligible to participate in our clinical trials.
CLINICAL TRIALS
Our Heartfelt Thanks
We know that advancing scientific discovery is not possible without dedicated patient volunteers and researchers working together. Talking to your healthcare team can help you know whether a clinical trial is right for you and determine whether you are eligible to participate in our clinical trials.